Bristol-Myers Squibb Company Stock price

Equities

BMY

US1101221083

Pharmaceuticals

Real-time Estimate Cboe BZX 10:55:53 2024-03-28 am EDT 5-day change 1st Jan Change
53.74 USD +0.92% Intraday chart for Bristol-Myers Squibb Company +4.10% +4.67%
Sales 2024 * 45.85B Sales 2025 * 46.35B Capitalization 108B
Net income 2024 * 7.19B Net income 2025 * 10.52B EV / Sales 2024 * 3.09 x
Net Debt 2024 * 33.89B Net Debt 2025 * 25.64B EV / Sales 2025 * 2.88 x
P/E ratio 2024 *
14.2 x
P/E ratio 2025 *
9.56 x
Employees 34,100
Yield 2024 *
4.56%
Yield 2025 *
4.76%
Free-Float 69.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.14%
1 week+2.64%
Current month+4.93%
1 month+5.42%
3 months+3.98%
6 months-8.02%
Current year+3.78%
More quotes
1 week
51.52
Extreme 51.5208
53.69
1 month
50.28
Extreme 50.275
55.04
Current year
47.58
Extreme 47.58
55.04
1 year
47.58
Extreme 47.58
71.07
3 years
47.58
Extreme 47.58
81.44
5 years
42.48
Extreme 42.48
81.44
10 years
42.48
Extreme 42.48
81.44
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 15-01-31
Chairman 59 99-12-31
Director of Finance/CFO 55 19-11-19
Members of the board TitleAgeSince
Director/Board Member 66 19-11-19
Director/Board Member 59 16-03-31
Director/Board Member 59 20-08-31
More insiders
Date Price Change Volume
24-03-28 53.73 +0.90% 1 404 397
24-03-27 53.25 +1.33% 13,077,608
24-03-26 52.55 +0.57% 9,951,952
24-03-25 52.25 +0.62% 12,348,068
24-03-22 51.93 +0.66% 11,727,720

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
27
Last Close Price
53.25 USD
Average target price
56.41 USD
Spread / Average Target
+5.94%
Consensus
  1. Stock
  2. Equities
  3. Stock Bristol-Myers Squibb Company - Nyse